Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers

Clinical trial NCT00189540 · COMPLETED

Trial details

NCT number: NCT00189540
Sponsor: AnGes USA, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arterial Occlusive Disease Peripheral Vascular Disease Ischemia Ulcers

Start date: 2005-08-01
Primary completion: 2008-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.